NextPlat Corp - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

More Details of NextPlat Corp Company

NextPlat Corp is a global e-commerce and healthcare company. Its e-Commerce Operations segment involves acquiring and leasing, an e-commerce platform to collaborate with businesses to optimize their ability to sell their goods online, domestically, and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue, and other related businesses. Its Healthcare Operations segment provides third-party administration, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, compounded medications, tele pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, medication adherence packaging, contracted pharmacy services for 340B covered entities. It provides Mobile Satellite Services solutions for satellite-enabled voice, data, personnel and asset tracking, Machine-to-Machine and Internet of Things connectivity services.

NextPlat Corp Info



Ticker SymbolNXPL

Company nameNextPlat Corp

IPO dateMar 15, 1999

CEOMr. David Phipps

Number of employees162

Security typeOrdinary Share

Fiscal year-endMar 15

Address3250 Mary St

CityCOCONUT GROVE

Stock exchangeNASDAQ Capital Market Consolidated

CountryUnited States of America

Postal code33133

Phone13055605355

Websitehttps://ir.nextplat.com/

Ticker SymbolNXPL

IPO dateMar 15, 1999

CEOMr. David Phipps

Company Executives of NextPlat Corp



Name

Name/Position

Position

Shareholding

Change

Mr. Rodney Barreto

Non-Executive Independent Chairman of the Board

2.24M

+36.14%

Mr. David Phipps

President, Chief Executive Officer, Director, Chief Executive Officer - Global Operations

621.79K

+47.42%

Ms. Elizabeth Alcaine

Independent Director

60.57K

--

Mr. Anthony Armas

Independent Director

60.57K

--

Mr. Louis Cusimano

Independent Director

35.43K

-36.08%

Mr. Hector Delgado

Independent Director

24.60K

--

Mr. Douglas S. Ellenoff

Vice Chairman of the Board, Chief Business Development Strategist

--

Mr. Robert Bedwell

Chief Compliance Officer

--

Mr. Michael Glickman

Investor Relations

--

Ms. Amanda L. Ferrio

Chief Financial Officer

--

Name

Name/Position

Position

Shareholding

Change

Mr. Rodney Barreto

Non-Executive Independent Chairman of the Board

2.24M

+36.14%

Mr. David Phipps

President, Chief Executive Officer, Director, Chief Executive Officer - Global Operations

621.79K

+47.42%

Ms. Elizabeth Alcaine

Independent Director

60.57K

--

Mr. Anthony Armas

Independent Director

60.57K

--

Mr. Louis Cusimano

Independent Director

35.43K

-36.08%

Mr. Hector Delgado

Independent Director

24.60K

--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

By BusinessUSD

Name

Revenue

Proportion

Pharmacy Prescription And Other Revenue Net Of Pbm Fees

8.17M

61.73%

e-Commerce revenue

4.12M

31.12%

Pharmacy 340B contract revenue

947.00K

22.99%

By RegionUSD

Name

Revenue

Proportion

Europe

1.99M

48.37%

North America

1.28M

31.17%

Asia & Pacific

641.00K

15.56%

Africa

188.00K

4.56%

South America

14.00K

0.34%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Pharmacy Prescription And Other Revenue Net Of Pbm Fees

8.17M

61.73%

e-Commerce revenue

4.12M

31.12%

Pharmacy 340B contract revenue

947.00K

22.99%

Shareholding Stats

Updated: Fri, Oct 31

Shareholders

Shareholder Types

Shareholders

Proportion

Fernandez (Charles M)

17.69%

Frost Gamma Investments Trust

13.21%

Barreto (Rodney)

8.63%

Keyser (Robert)

3.77%

Phipps (David)

2.39%

Other

54.31%

Shareholders

Proportion

Fernandez (Charles M)

17.69%

Frost Gamma Investments Trust

13.21%

Barreto (Rodney)

8.63%

Keyser (Robert)

3.77%

Phipps (David)

2.39%

Other

54.31%

Shareholder Types

Shareholders

Proportion

Individual Investor

34.31%

Corporation

13.21%

Investment Advisor

5.53%

Investment Advisor/Hedge Fund

1.04%

Hedge Fund

0.13%

Venture Capital

0.07%

Other

45.71%

Institutional Shareholding



Updated: Wed, Oct 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q3

34

1.76M

6.77%

+471.08K

2025Q2

43

13.26M

51.07%

+1.66M

2025Q1

43

11.85M

60.63%

+595.42K

2024Q4

41

12.22M

47.07%

+1.42M

2024Q3

33

11.44M

52.41%

+839.72K

2024Q2

34

11.11M

57.81%

+518.97K

2024Q1

35

11.08M

58.38%

+876.45K

2023Q4

35

10.68M

71.96%

+7.69M

2023Q3

37

11.28M

76.50%

+7.16M

2023Q2

40

11.24M

76.32%

+7.16M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Fernandez (Charles M)

4.59M

17.69%

+687.04K

+17.59%

Apr 28, 2025

Frost Gamma Investments Trust

3.43M

13.21%

--

Apr 28, 2025

Barreto (Rodney)

2.24M

8.63%

+594.49K

+36.14%

Apr 28, 2025

Keyser (Robert)

979.50K

3.77%

+78.75K

+8.74%

Apr 28, 2025

Phipps (David)

621.79K

2.39%

+200.00K

+47.42%

Sep 26, 2025

EverSource Wealth Advisors, LLC

580.69K

2.24%

--

Jun 30, 2025

Geode Capital Management, L.L.C.

223.30K

0.86%

+5.87K

+2.70%

Jun 30, 2025

Hough (Jervis Bennett)

127.67K

0.49%

+127.67K

--

Oct 01, 2024

Ellenoff (Douglas S.)

125.00K

0.48%

--

Apr 28, 2025

Related ETFs



Updated: Sun, Nov 2

Name

Proportion

iShares Micro-Cap ETF

0%

Fidelity Nasdaq Composite Index ETF

0%

Dimensional US Core Equity 1 ETF

0%

iShares Micro-Cap ETF

Proportion0%

Fidelity Nasdaq Composite Index ETF

Proportion0%

Dimensional US Core Equity 1 ETF

Proportion0%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split



Date

Type

Ratio

No Data

Date

Type

Ratio

No Data